Ado-trastuzumab emtansine Interactions
There are 292 drugs known to interact with ado-trastuzumab emtansine, along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 56 are major, and 236 are moderate.
- View all 292 medications that may interact with ado-trastuzumab emtansine
- View ado-trastuzumab emtansine alcohol/food interactions (1)
- View ado-trastuzumab emtansine disease interactions (5)
Most frequently checked interactions
View interaction reports for ado-trastuzumab emtansine and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Acephen (acetaminophen)
- Adriamycin (doxorubicin)
- Advil Liqui-Gels (ibuprofen)
- Aleve (naproxen)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- Cheratussin AC (codeine / guaifenesin)
- Claritin 24 Hour Allergy (loratadine)
- Coreg (carvedilol)
- Ditropan XL (oxybutynin)
- Emend (aprepitant)
- Ex-Lax Regular Strength Pills (senna)
- Fentanyl Transdermal System (fentanyl)
- Flintstones Complete (multivitamin with iron)
- Gas-X Extra Strength (simethicone)
- Herceptin (trastuzumab)
- IBU (ibuprofen)
- Inderal LA (propranolol)
- Iron Sulfate (ferrous sulfate)
- Klor-Con/EF (potassium bicarbonate)
- Lyrica (pregabalin)
- Maxzide (hydrochlorothiazide / triamterene)
- Melatonin Time Release (melatonin)
- Metoprolol Succinate ER (metoprolol)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Zantac (ranitidine)
Ado-trastuzumab emtansine alcohol/food interactions
There is 1 alcohol/food interaction with ado-trastuzumab emtansine.
Ado-trastuzumab emtansine disease interactions
There are 5 disease interactions with ado-trastuzumab emtansine which include:
Report options
More about ado-trastuzumab emtansine
- ado-trastuzumab emtansine consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.